Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyper Eosinophilic Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00266565
What this trial is testing

Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

Who this might be right for
Hypereosinophilic SyndromesEosinophilic GastroenteritisChurg-Strauss Syndrome+1 more
Children's Hospital Medical Center, Cincinnati 24
Not applicableLooking for participantsNCT06422078
What this trial is testing

A Non-interventional, Prospective Study With Benralizumab

Who this might be right for
Asthma, Bronchial
AstraZeneca 300
Post-approval studies (Phase 4)UnknownNCT04585997
What this trial is testing

Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".

Who this might be right for
AsthmaEosinophilic Asthma
University of Newcastle, Australia 200
Early research (Phase 1)UnknownNCT05584306
What this trial is testing

A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT03610685
What this trial is testing

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Who this might be right for
Asthma
NHS Greater Glasgow and Clyde 33
Large-scale testing (Phase 3)Study completedNCT01270464
What this trial is testing

Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 315
Testing effectiveness (Phase 2)Looking for participantsNCT07323654
What this trial is testing

KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Kymera Therapeutics, Inc. 264
Testing effectiveness (Phase 2)Study completedNCT04046939
What this trial is testing

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

Who this might be right for
Eosinophilic AsthmaAsthma
Knopp Biosciences 534
Not applicableStudy completedNCT06172751
What this trial is testing

TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary Cause

Who this might be right for
Hypereosinophilic Syndrome (HES)
AstraZeneca 250
Not applicableNot Yet RecruitingNCT06911775
What this trial is testing

Eosinophil Subpopulations in Eosinophilic-associated Diseases

Who this might be right for
Eosinophilic AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
University of Florence 160
Large-scale testing (Phase 3)Study completedNCT01508936
What this trial is testing

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 511
Large-scale testing (Phase 3)Study completedNCT02281318
What this trial is testing

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

Who this might be right for
Asthma
GlaxoSmithKline 556
Testing effectiveness (Phase 2)Study completedNCT03469934
What this trial is testing

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
AnaptysBio, Inc. 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Post-approval studies (Phase 4)Study completedNCT04710134
What this trial is testing

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Who this might be right for
Asthma; Eosinophilic
McMaster University 10
Post-approval studies (Phase 4)Enrolling By InvitationNCT07343661
What this trial is testing

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

Who this might be right for
EGPA - Eosinophilic Granulomatosis With PolyangiitisSevere AsthmaEosinophilic Asthma
Azienda Ospedaliero Universitaria di Cagliari 90
Post-approval studies (Phase 4)Study completedNCT01524536
What this trial is testing

Steroid Treatment for Hypereosinophilic Syndrome

Who this might be right for
EosinophiliaHypereosinophilic SyndromeLeukocyte Disorder+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableStudy completedNCT05440656
What this trial is testing

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 152
Not applicableUnknownNCT03739320
What this trial is testing

A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma

Who this might be right for
Severe Eosinophilic Asthma
Sotiria General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00255346
What this trial is testing

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesAgnogenic Myeloid Metaplasia+5 more
M.D. Anderson Cancer Center 68
Next Page